Inherited cardiac diseases, including genetic cardiomyopathies and primary arrhythmia syndromes, with particular focus on the following areas:

• Natural disease history and pathomechanisms: cohort studies and translational investigations to elucidate disease course and underlying pathophysiology.
• Genetic architecture and phenotype modulation: investigating genotype-phenotype relationships and identifying genetic and non-genetic modifiers of disease onset and severity.
• Risk stratification and prevention: development and validation of risk prediction models to enable targeted preventive interventions.
• Therapeutic innovation: clinical translation and evaluation of emerging therapies, including gene- and RNA-based approaches, with a focus on integrating clinical and scientific insights into trial design and execution.
• European collaboration and rare disease policy: coordination of cross-border initiatives (e.g. via European Reference Network for rare cardiac diseases and European Society of Cardiology) to improve care for patients and at-risk relatives, and to establish a sustainable foundation for future research in genetic cardiology.

General cardiology, genetic cardiology, arrhythmia, heart failure